Intralesional bleomycin for warts: a review.

Area of Science:

• Dermatology
• Pharmacology

Background:

• Intralesional bleomycin has been a recognized treatment for warts since the 1970s.
• Limited randomized placebo-controlled trials exist comparing it to other local wart treatments.
• Numerous case reports document its use for recalcitrant warts.

Purpose of the Study:

• To review the efficacy, safety, and administration of intralesional bleomycin for wart treatment.
• To consolidate existing evidence on bleomycin's effectiveness in managing warts.

Main Methods:

• Literature review of published reports and studies on intralesional bleomycin for warts.
• Analysis of cure rates, side effects, and administration techniques from existing data.

Main Results:

• Reported cure rates for intralesional bleomycin in warts range widely from 14% to 99%.
• The majority of data indicates efficacy in over two-thirds of treated cases.
• Bleomycin treatment for warts is associated with minimal side effects.

Conclusions:

• Intralesional bleomycin demonstrates significant efficacy in treating recalcitrant warts.
• Further high-quality clinical trials are warranted to establish its comparative effectiveness.
• Understanding its mechanism, pharmacokinetics, and safety profile is crucial for optimal use.